Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRN-157 in stable mild and moderate asthmatics
NCT02382510Phase 2Completed
- Sponsor
- Theron Pharmaceuticals
- Start
- Apr 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of trn-157 in asthma (3 arms), sponsored by Theron Pharmaceuticals. Primary endpoints: Change from baseline in FEV1 at 2 weeks and Safety and tolerability as determined by number of subjects with adverse events at 2 weeks. Started Apr 2015; status: completed.
02
Drugs
trn-157
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02382510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02382510.